Holding(s) in Company

 
RNS Number : 3977Y
African Pioneer PLC
02 January 2024
 
African Pioneer Plc
(“African Pioneer” or the “Company”)
 
Holding(s) in Company
 

African Pioneer plc (“AFP” or the “Company”) the exploration and resource development company with advanced projects in Namibia, Botswana, and Zambia, has received a TR-1 notification which is set out below without amendment

For further information, please contact:

African Pioneer Plc

Colin Bird, Chairman

Tel +44 (0) 20 7581 4477
Beaumont Cornish Limited (Financial Adviser)

Roland Cornish/Asia Szusciak

Tel +44 (0) 20 7628 3396
Novum Securities Limited (Broker)

Jon Belliss

Tel +44 (0) 20 7399 9400

or visit   https://africanpioneerplc.com/ 

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

im00b8c0hk22

Issuer Name

AFRICAN PIONEER PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Jonathan Mark Swann

City of registered office (if applicable)

rickmansworth

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

29-Dec-2023

6. Date on which Issuer notified

02-Jan-2024

7. Total positions of person(s) subject to the notification obligation

. % of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached 7.040000 0.000000 7.040000 16055556
Position of previous notification (if applicable) 6.820000 0.000000 6.820000  

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
im00b8c0hk22 16055556 0 7.040000 0.000000
Sub Total 8.A 16055556 7.040000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights
         
Sub Total 8.B1      

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
           
Sub Total 8.B2      

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold
         

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

none

12. Date of Completion

31-Dec-2023

13. Place Of Completion

London

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 

END